Effect of nitric oxide–cyclic GMP–K+ channel pathway blockers, naloxone and metformin, on the antinociception induced by the diuretic pamabrom
MI Ortiz, R Cariño-Cortés… - Canadian Journal of …, 2022 - cdnsciencepub.com
Pamabrom is a diuretic that is effective in treating premenstrual syndrome and primary
dysmenorrhea. The aim of this study was to examine the effect of metformin and modulators …
dysmenorrhea. The aim of this study was to examine the effect of metformin and modulators …
Role of the NO-cGMP-K+ channels pathway in the peripheral antinociception induced by α-bisabolol
MI Ortiz, R Cariño-Cortés… - Canadian Journal of …, 2021 - cdnsciencepub.com
The aim of this study was to examine if the peripheral antinociception of α-bisabolol involves
the participation of nitric oxide (NO) and cyclic guanosine monophosphate (cGMP) synthesis …
the participation of nitric oxide (NO) and cyclic guanosine monophosphate (cGMP) synthesis …
The κ-opioid agonist (±)-bremazocine elicits peripheral antinociception by activation of the L-arginine/nitric oxide/cyclic GMP pathway
LH Amarante, IDG Duarte - European Journal of Pharmacology, 2002 - Elsevier
In view of the scarce information about the analgesic mechanism of κ-opioid receptor
agonists, the objective of the present study was to determine whether nitric oxide (NO) is …
agonists, the objective of the present study was to determine whether nitric oxide (NO) is …
Participation of the opioid receptor – nitric oxide – cGMP – K+ channel pathway in the peripheral antinociceptive effect of nalbuphine and buprenorphine in rats
MI Ortiz, R Cariño-Cortés… - Canadian Journal of …, 2020 - cdnsciencepub.com
The aim of this study was to examine if the peripheral antinociceptive effects of the opioid
agonist/antagonist nalbuphine and buprenorphine involve the sequential participation of …
agonist/antagonist nalbuphine and buprenorphine involve the sequential participation of …
Noradrenaline activates the NO/cGMP/ATP-sensitive K+ channels pathway to induce peripheral antinociception in rats
TRL Romero, LS Guzzo, AC Perez, A Klein, IDG Duarte - Nitric oxide, 2012 - Elsevier
Despite the classical peripheral pronociceptive effect of noradrenaline (NA), recently studies
showed the involvement of NA in antinociceptive effect under immune system interaction. In …
showed the involvement of NA in antinociceptive effect under immune system interaction. In …
Study of the involvement of K+ channels in the peripheral antinociception of the κ-opioid receptor agonist bremazocine
LH Amarante, DP Alves, IDG Duarte - European journal of pharmacology, 2004 - Elsevier
The involvement of the nitric oxide (NO)/cyclic GMP pathway in the molecular mechanisms
of antinociceptive drugs like morphine has been previously shown by our group …
of antinociceptive drugs like morphine has been previously shown by our group …
Participation of the nitric oxide–cyclic GMP–ATP-sensitive K+ channel pathway in the antinociceptive action of ketorolac
GG Lázaro-Ibáñez, JE Torres-López… - European journal of …, 2001 - Elsevier
The involvement of nitric oxide (NO), cyclic GMP and ATP-sensitive K+ channels in the
antinociceptive effect of ketorolac was assessed using the formalin test in the rat. Local …
antinociceptive effect of ketorolac was assessed using the formalin test in the rat. Local …
Ketamine activates the L-arginine/nitric oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats
TRL Romero, GS Galdino, GC Silva… - Anesthesia & …, 2011 - journals.lww.com
BACKGROUND: The involvement of the l-arginine/nitric oxide (NO)/cyclic guanosine
monophosphate (cGMP) pathway in antinociception has been implicated as a molecular …
monophosphate (cGMP) pathway in antinociception has been implicated as a molecular …
Probable activation of the opioid receptor-nitric oxide-cyclic GMP-K+ channels pathway by codeine
MI Ortiz, J Castro-Olguín, N Peña-Samaniego… - Pharmacology …, 2005 - Elsevier
There is evidence that local peripheral administration of morphine produces antinociception
through the activation of the nitric oxide (NO)-cyclic GMP-K+ channels pathway. Therefore …
through the activation of the nitric oxide (NO)-cyclic GMP-K+ channels pathway. Therefore …
The NO–cGMP–K+ channel pathway participates in the antinociceptive effect of diclofenac, but not of indomethacin
MI Ortiz, V Granados-Soto… - Pharmacology …, 2003 - Elsevier
The aim of this study was to examine if the peripheral antinociceptive effects of diclofenac
and indomethacin involve the sequential participation of NO and cGMP synthesis followed …
and indomethacin involve the sequential participation of NO and cGMP synthesis followed …
相关搜索
- nitric oxide channel pathway
- nitric oxide cyclic gmp
- channel pathway cyclic gmp
- channel pathway peripheral antinociception
- channel pathway opioid receptor
- nitric oxide opioid receptor
- gmp pathway κ opioid
- nitric oxide buprenorphine in rats
- channel pathway buprenorphine in rats
- channel pathway α bisabolol
- channel pathway synergistic interaction
- antinociceptive action cyclic gmp
- nitric oxide antinociceptive action
- gmp pathway peripheral antinociception
- channel pathway antinociceptive effect
- channel pathway nalbuphine and buprenorphine